Roche says FDA fast tracks atezolizumab in specific type of lung cancer
ZURICH Roche Holding AG said on Monday the U.S. Food and Drug Administration has granted priority review for atezolizumab for treating people with a specific type of lung cancer. The designation covers treatment of patients with locally advanced or metastatic ... More »
